Respiratory disease companies develop therapies, diagnostics and research technologies for conditions affecting the lungs and airways. Their work supports earlier detection, improved disease monitoring and the development of treatments for acute, chronic and inherited pulmonary disorders.
This category includes companies working on:
Browse 65 UK respiratory disease companies below.
Computationally designed broadly protective vaccines against pandemic viruses
DIOSynVax is a clinical-stage biotechnology company developing broadly protective vaccines using a computational antigen design platform. The company's technology applies protein…
Cocrystal drug repurposing for oncology supportive care and fibrosis
Nuformix is a pharmaceutical development company using proprietary cocrystal technology to repurpose existing drugs for unmet medical needs in fibrosis and oncology. By…
Preclinical in vitro bioassay CRO for drug discovery programmes
Cellomatics Biosciences is a UK-based contract research organisation providing bespoke preclinical in vitro bioassay services to biotechnology and pharmaceutical clients. The…
Targeted oral drug delivery platform for cancer, CNS and respiratory disease
TRX Biosciences is a biotechnology company developing a targeted oral drug delivery platform, enabling therapies to reach specific organs, cells and tissues for cancer, central…
3D cell culture scaffolds and human tissue services for drug research
REPROCELL is a life science company combining proprietary 3D cell culture products with ex vivo human tissue testing services for the pharmaceutical industry. Its scaffold enables…
Global generics and specialty pharmaceutical manufacturer headquartered in London
Hikma Pharmaceuticals is a multinational pharmaceutical company developing, manufacturing and marketing generic, specialty and branded medicines across injectable, oral and…
Small molecule therapies for cystic fibrosis and COPD
Enterprise Therapeutics is a clinical-stage biopharmaceutical company developing novel muco-regulatory therapies for respiratory diseases. Its lead programme ETD001 is a…
Clinical gamma scintigraphy for pharmaceutical formulation evaluation
Cardiff Scintigraphics is an independent contract research company specialising in gamma scintigraphy, a clinical imaging technique using radiolabelled drug formulations to…
AI imaging platform for lung and heart disease clinical trials
Qureight is a technology-driven imaging contract research organisation providing clinical data curation and AI-powered image analysis services to pharmaceutical and biotech…
Non-viral gene therapy platform enabling durable nuclear DNA delivery
Gramics Bio develops a gene therapy platform solving a key limitation of lipid nanoparticle delivery: enabling therapeutic DNA to reach the cell nucleus for durable expression…
Specialist pharma acquiring and developing rare disease therapeutics
Ambrose Healthcare is a UK specialist pharmaceutical company developing treatments for rare diseases and patients in hospital and specialist care settings. The company builds its…
Drug-free nasal barrier spray blocking airborne viruses and allergens
Birmingham Biotech is a University of Birmingham spin-out selling NoriZite, a drug-free nasal spray that creates a structured fluid-gel barrier in the nasal cavity for up to six…